These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 38793802)

  • 21. Disease Flares Following COVID-19 Vaccination in Patients with Inflammatory Bowel Disease.
    Yoshida Y; Fujioka S; Moriyama T; Umeno J; Kawasaki K; Fuyuno Y; Matsuno Y; Ihara Y; Torisu T; Kitazono T
    Intern Med; 2023 Dec; 62(24):3579-3584. PubMed ID: 37779068
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patients with IBD have a more cautious attitude towards COVID-19 vaccination.
    Hu S; Liu J; Li S; Wu Q; Wang X; Xu D; Chen Y
    Front Immunol; 2022; 13():1077308. PubMed ID: 36741375
    [TBL] [Abstract][Full Text] [Related]  

  • 23. COVID-19 Vaccination Among Individuals With Inflammatory Bowel Disease: Perception, Efficacy, and Safety.
    Weaver KN; Kappelman MD; Long MD
    Gastroenterol Hepatol (N Y); 2022 Jul; 18(7):388-399. PubMed ID: 36397773
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Impact of Inflammatory Bowel Disease in Canada 2018: Direct Costs and Health Services Utilization.
    Kuenzig ME; Benchimol EI; Lee L; Targownik LE; Singh H; Kaplan GG; Bernstein CN; Bitton A; Nguyen GC; Lee K; Cooke-Lauder J; Murthy SK
    J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S17-S33. PubMed ID: 31294382
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Canadian Association of Gastroenterology Clinical Practice Guideline for Immunizations in Patients With Inflammatory Bowel Disease (IBD)-Part 2: Inactivated Vaccines.
    Jones JL; Tse F; Carroll MW; deBruyn JC; McNeil SA; Pham-Huy A; Seow CH; Barrett LL; Bessissow T; Carman N; Melmed GY; Vanderkooi OG; Marshall JK; Benchimol EI
    Gastroenterology; 2021 Aug; 161(2):681-700. PubMed ID: 34334167
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Can we better protect patients with inflammatory bowel disease against infections - patient attitude and personal immunization knowledge.
    Waszczuk K; Waszczuk E; Szenborn L
    Acta Gastroenterol Belg; 2018; 81(2):257-261. PubMed ID: 30024696
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patients With Inflammatory Bowel Diseases Have Impaired Antibody Production After Anti-SARS-CoV-2 Vaccination: Results From a Panhellenic Registry.
    Zacharopoulou E; Orfanoudaki E; Tzouvala M; Tribonias G; Kokkotis G; Kitsou V; Almpani F; Christidou A; Viazis N; Mantzaris GJ; Tsafaridou M; Karmiris K; Theodoropoulou A; Papathanasiou E; Zampeli E; Michopoulos S; Tigkas S; Michalopoulos G; Laoudi E; Karatzas P; Mylonas I; Kyriakos N; Liatsos C; Kafetzi T; Theocharis G; Taka S; Panagiotopoulou K; Koutroubakis IE; Bamias G
    Inflamm Bowel Dis; 2023 Feb; 29(2):228-237. PubMed ID: 35394529
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Implementation and Short-term Adverse Events of Anti-SARS-CoV-2 Vaccines in Inflammatory Bowel Disease Patients: An International Web-based Survey.
    Ellul P; Revés J; Abreu B; Chaparro M; Gisbert JP; Allocca M; Fiorino G; Barberio B; Zingone F; Pisani A; Cassar D; Michalopoulos G; Mantzaris G; Koutroubakis I; Karmiris K; Katsanos K; Ďuricova D; Burisch J; Madsen GR; Maaser C; Naila A; Orfanoudaki E; Milivojevic V; Buisson A; Avedano L; Leone S; Torres J
    J Crohns Colitis; 2022 Aug; 16(7):1070-1078. PubMed ID: 35037033
    [TBL] [Abstract][Full Text] [Related]  

  • 29. COVID-19 Vaccination in Inflammatory Bowel Disease (IBD).
    Kubas A; Malecka-Wojciesko E
    J Clin Med; 2022 May; 11(9):. PubMed ID: 35566802
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Four SARS-CoV-2 vaccine doses or hybrid immunity in patients on immunosuppressive therapies: a Norwegian cohort study.
    Bjørlykke KH; Ørbo HS; Tveter AT; Jyssum I; Sexton J; Tran TT; Christensen IE; Kro GB; Kvien TK; Jahnsen J; Munthe LA; Chopra A; Warren DJ; Mjaaland S; Haavardsholm EA; Grødeland G; Provan SA; Vaage JT; Syversen SW; Goll GL; Jørgensen KK
    Lancet Rheumatol; 2023 Jan; 5(1):e36-e46. PubMed ID: 36415604
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patient education interventions for the management of inflammatory bowel disease.
    Gordon M; Sinopoulou V; Ibrahim U; Abdulshafea M; Bracewell K; Akobeng AK
    Cochrane Database Syst Rev; 2023 May; 5(5):CD013854. PubMed ID: 37172140
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of gastroenterologists and healthcare providers in promoting COVID-19 immunization among individuals with inflammatory bowel disease: A systematic review and meta-analysis on a global scale.
    Bianchi FP; Polignano M; Carella N; Rotolo O; Curlo M; Mastronardi M
    Hum Vaccin Immunother; 2024 Dec; 20(1):2349319. PubMed ID: 38755111
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Canadian Association of Gastroenterology Clinical Practice Guideline for Immunizations in Patients With Inflammatory Bowel Disease (IBD)-Part 1: Live Vaccines.
    Benchimol EI; Tse F; Carroll MW; deBruyn JC; McNeil SA; Pham-Huy A; Seow CH; Barrett LL; Bessissow T; Carman N; Melmed GY; Vanderkooi OG; Marshall JK; Jones JL
    Gastroenterology; 2021 Aug; 161(2):669-680.e0. PubMed ID: 33617891
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Humoral Immunogenicity After Vaccination Against SARS-CoV-2 Infection in Inflammatory Bowel Disease Patients Under Immunosuppressive Therapy: Should We Prioritize an Additional Booster Injection?
    Macedo Silva V; Lima Capela T; Freitas M; Cúrdia Gonçalves T; Boal Carvalho P; Dias de Castro F; João Moreira M; Cotter J
    Inflamm Bowel Dis; 2023 Feb; 29(2):268-273. PubMed ID: 36099059
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A retrospective, case-control study on traditional environmental risk factors in inflammatory bowel disease in Vukovar-Srijem County, north-eastern Croatia, 2010.
    Vcev A; Pezerovic D; Jovanovic Z; Nakic D; Vcev I; Majnarić L
    Wien Klin Wochenschr; 2015 May; 127(9-10):345-54. PubMed ID: 25821054
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of COVID-19 vaccination campaign on pediatric vaccine uptake based on parents' attitudes towards mandatory and recommended vaccination in Southern Italy.
    Baglivo F; De Angelis L; Magrì M; De Nicola I; De Vita E; Lopalco PL; Rizzo C; Fedele A
    Vaccine; 2024 Jun; 42(16):3615-3620. PubMed ID: 38704254
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety of Recombinant Zoster Vaccine in Patients with Inflammatory Bowel Disease.
    Satyam VR; Li PH; Reich J; Qazi T; Noronha A; Wasan SK; Farraye FA
    Dig Dis Sci; 2020 Oct; 65(10):2986-2991. PubMed ID: 31897892
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of SARS-CoV-2 vaccine (Vero cells) on disease activity in patients with inflammatory bowel disease in China: a multicenter study.
    Zhang M; Huang Q; Shi C; Feng Y; Duan T; Lin T; Zhu Y; Liu G; Li H; Liu Y; Jiang B
    Int J Colorectal Dis; 2023 Feb; 38(1):31. PubMed ID: 36757427
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vaccinations in patients with inflammatory bowel disease.
    Macaluso FS; Liguori G; Galli M
    Dig Liver Dis; 2021 Dec; 53(12):1539-1545. PubMed ID: 34116972
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of COVID-19 vaccines on patient-reported outcomes in patients with inflammatory bowel disease: a multicenter survey study in Korea.
    Ji JH; Shin SH; Park YE; Park J; Park JJ; Cheon JH; Kim TI; Kang SB; Park SH; Park SJ;
    Intest Res; 2024 Jul; 22(3):336-350. PubMed ID: 38523453
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.